Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma is a research paper published in American Journal of Hematology (2021). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: Lymphoma Epidemiology of Outcomes U01CA195568
National Cancer Institute
Grant: University of Iowa/Mayo Clinic SPORE P50CA097274
NCI NIH HHS
Grant: P50 CA097274
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: U01 CA195568
FWCI
2.42
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords